Published in
Elsevier, European Journal of Cancer, (156), p. 12-23, 2021
DOI: 10.1016/j.ejca.2021.07.016
Links
Tools
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
Journal article published in 2021 by
Patrick Schöffski 
,
Michaela Kubickova,
Agnieszka Wozniak ,
Jean-Yves Blay ,
Sandra J. Strauss,
Silvia Stacchiotti ,
Tomasz Switaj,
Veit Bücklein ,
Michael G. Leahy,
Antoine Italiano,
Nicolas Isambert,
Maria Debiec-Rychter,
Raf Sciot,
Che-Jui Lee ,
Frank M. Speetjens
and other authors.
,
Michaela Kubickova,
Agnieszka Wozniak ,
Jean-Yves Blay ,
Sandra J. Strauss,
Silvia Stacchiotti ,
Tomasz Switaj,
Veit Bücklein ,
Michael G. Leahy,
Antoine Italiano,
Nicolas Isambert,
Maria Debiec-Rychter,
Raf Sciot,
Che-Jui Lee ,
Frank M. Speetjens
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 